Xylem price target raised to $168 from $164 at UBS

UBS raised the firm’s price target on Xylem (XYL) to $168 from $164 and keeps a Buy rating on the shares. Xylem’s Q2 results indicate the company is still flowing through relatively smooth waters, the analyst tells investors in a research note.